Renal cell carcinoma: Relevance of pathology

Mototsugu Oya, Masaru Murai

Research output: Contribution to journalArticle

4 Citations (Scopus)

Abstract

Purpose of review: Although pathological findings including tumour grade and tumour-node-metastasis stage provide prognostic information, the outcome for patients with renal cell carcinoma is occasionally unpredictable. Many studies have been undertaken to improve prediction of the prognosis of renal cell carcinoma, along with efforts to clarify the pathogenesis of renal cell carcinoma at the molecular level. This article reviews the advances in renal cell carcinoma research relevant to pathology published between 1 May 2002 and 30 April 2003. Recent findings: The establishment of a strict tumour grading system or adding microscopic venous invasion or tumour necrosis is potentially useful for predicting patient outcomes. The contribution of the von Hippel-Lindau-related pathway in early carcinogenesis has been partly revealed with regard to angiogenesis and cell cycle control. Tumour development in renal cell carcinoma can be considered as accumulating heterogenous molecular events related to cytokine production, cell cycle control, anti-apoptotic signal machinery and angiogenesis. Summary: Finding the target genes related to the von Hippel-Lindau pathway may explain the resistance of chemotherapy, and also provide a clue to finding a novel therapeutic option. Molecular targeting therapy can be applicable after more general molecules leading to tumour development and the metastasis of renal cell carcinoma have been identified.

Original languageEnglish
Pages (from-to)445-449
Number of pages5
JournalCurrent Opinion in Urology
Volume13
Issue number6
DOIs
Publication statusPublished - 2003 Nov

Fingerprint

Renal Cell Carcinoma
Pathology
Neoplasms
Cell Cycle Checkpoints
Neoplasm Metastasis
Neoplasm Grading
Carcinogenesis
Necrosis
Cytokines
Drug Therapy
Therapeutics
Research
Genes

Keywords

  • Carcinogenesis
  • Pathology
  • Renal cell carcinoma
  • Tumour development

ASJC Scopus subject areas

  • Urology

Cite this

Renal cell carcinoma : Relevance of pathology. / Oya, Mototsugu; Murai, Masaru.

In: Current Opinion in Urology, Vol. 13, No. 6, 11.2003, p. 445-449.

Research output: Contribution to journalArticle

Oya, Mototsugu ; Murai, Masaru. / Renal cell carcinoma : Relevance of pathology. In: Current Opinion in Urology. 2003 ; Vol. 13, No. 6. pp. 445-449.
@article{0f6bc10f4ebf4b708a54ecab28cd1427,
title = "Renal cell carcinoma: Relevance of pathology",
abstract = "Purpose of review: Although pathological findings including tumour grade and tumour-node-metastasis stage provide prognostic information, the outcome for patients with renal cell carcinoma is occasionally unpredictable. Many studies have been undertaken to improve prediction of the prognosis of renal cell carcinoma, along with efforts to clarify the pathogenesis of renal cell carcinoma at the molecular level. This article reviews the advances in renal cell carcinoma research relevant to pathology published between 1 May 2002 and 30 April 2003. Recent findings: The establishment of a strict tumour grading system or adding microscopic venous invasion or tumour necrosis is potentially useful for predicting patient outcomes. The contribution of the von Hippel-Lindau-related pathway in early carcinogenesis has been partly revealed with regard to angiogenesis and cell cycle control. Tumour development in renal cell carcinoma can be considered as accumulating heterogenous molecular events related to cytokine production, cell cycle control, anti-apoptotic signal machinery and angiogenesis. Summary: Finding the target genes related to the von Hippel-Lindau pathway may explain the resistance of chemotherapy, and also provide a clue to finding a novel therapeutic option. Molecular targeting therapy can be applicable after more general molecules leading to tumour development and the metastasis of renal cell carcinoma have been identified.",
keywords = "Carcinogenesis, Pathology, Renal cell carcinoma, Tumour development",
author = "Mototsugu Oya and Masaru Murai",
year = "2003",
month = "11",
doi = "10.1097/00042307-200311000-00004",
language = "English",
volume = "13",
pages = "445--449",
journal = "Current Opinion in Urology",
issn = "0963-0643",
publisher = "Lippincott Williams and Wilkins",
number = "6",

}

TY - JOUR

T1 - Renal cell carcinoma

T2 - Relevance of pathology

AU - Oya, Mototsugu

AU - Murai, Masaru

PY - 2003/11

Y1 - 2003/11

N2 - Purpose of review: Although pathological findings including tumour grade and tumour-node-metastasis stage provide prognostic information, the outcome for patients with renal cell carcinoma is occasionally unpredictable. Many studies have been undertaken to improve prediction of the prognosis of renal cell carcinoma, along with efforts to clarify the pathogenesis of renal cell carcinoma at the molecular level. This article reviews the advances in renal cell carcinoma research relevant to pathology published between 1 May 2002 and 30 April 2003. Recent findings: The establishment of a strict tumour grading system or adding microscopic venous invasion or tumour necrosis is potentially useful for predicting patient outcomes. The contribution of the von Hippel-Lindau-related pathway in early carcinogenesis has been partly revealed with regard to angiogenesis and cell cycle control. Tumour development in renal cell carcinoma can be considered as accumulating heterogenous molecular events related to cytokine production, cell cycle control, anti-apoptotic signal machinery and angiogenesis. Summary: Finding the target genes related to the von Hippel-Lindau pathway may explain the resistance of chemotherapy, and also provide a clue to finding a novel therapeutic option. Molecular targeting therapy can be applicable after more general molecules leading to tumour development and the metastasis of renal cell carcinoma have been identified.

AB - Purpose of review: Although pathological findings including tumour grade and tumour-node-metastasis stage provide prognostic information, the outcome for patients with renal cell carcinoma is occasionally unpredictable. Many studies have been undertaken to improve prediction of the prognosis of renal cell carcinoma, along with efforts to clarify the pathogenesis of renal cell carcinoma at the molecular level. This article reviews the advances in renal cell carcinoma research relevant to pathology published between 1 May 2002 and 30 April 2003. Recent findings: The establishment of a strict tumour grading system or adding microscopic venous invasion or tumour necrosis is potentially useful for predicting patient outcomes. The contribution of the von Hippel-Lindau-related pathway in early carcinogenesis has been partly revealed with regard to angiogenesis and cell cycle control. Tumour development in renal cell carcinoma can be considered as accumulating heterogenous molecular events related to cytokine production, cell cycle control, anti-apoptotic signal machinery and angiogenesis. Summary: Finding the target genes related to the von Hippel-Lindau pathway may explain the resistance of chemotherapy, and also provide a clue to finding a novel therapeutic option. Molecular targeting therapy can be applicable after more general molecules leading to tumour development and the metastasis of renal cell carcinoma have been identified.

KW - Carcinogenesis

KW - Pathology

KW - Renal cell carcinoma

KW - Tumour development

UR - http://www.scopus.com/inward/record.url?scp=0442323421&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0442323421&partnerID=8YFLogxK

U2 - 10.1097/00042307-200311000-00004

DO - 10.1097/00042307-200311000-00004

M3 - Article

C2 - 14560136

AN - SCOPUS:0442323421

VL - 13

SP - 445

EP - 449

JO - Current Opinion in Urology

JF - Current Opinion in Urology

SN - 0963-0643

IS - 6

ER -